Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Mar;59(3):217-22.
doi: 10.1136/ard.59.3.217.

Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin

M Voulgarelis  1 , S I Kokori, J P Ioannidis, A G Tzioufas, D Kyriaki, H M Moutsopoulos
Affiliations

Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin

M Voulgarelis et al. Ann Rheum Dis. 2000 Mar.

Abstract

Objective: To study the prevalence of different causes of anaemia in patients with systemic lupus erythematosus (SLE) and their associations with immunological and clinical parameters and to evaluate the contribution of erythropoietin (Epo) and anti-erythropoietin (anti-Epo) autoantibodies to the development of SLE anaemia.

Methods: 132 SLE patients with anaemia (defined as haemoglobin of 12 g/dl or less for women and 13.5 g/dl or less for men) from among a total of 345 consecutive SLE patients were prospectively enrolled into the study. Standard haematological and immunological tests were performed and serum Epo and anti-Epo antibodies were assayed.

Results: The identified causes were anaemia of chronic disease (ACD) n=49 (37.1%), iron deficiency anaemia (IDA) n = 47 (35.6%), autoimmune haemolytic anaemia (AHA) n = 19 (14.4%) and other causes n = 17 (12.9%). There was significant heterogeneity in the severity of anaemia between the four groups (p<0.01) with AHA cases being on average more severe. The proportion of patients with anticardiolipin antibodies, low complement levels and anti-dsDNA differed significantly among the four groups; these markers were particularly common in patients with AHA, and uncommon in patients with IDA. Twenty one of 100 tested patients had anti-Epo antibodies. Such antibodies were seen practically only in patients with ACD (odds ratio 3.1, p = 0.041) and in patients with high lupus activity (ECLAM) scores (odds ratio 1.27 per point, p = 0.055). Epo response was inadequate in 42.4% and 41.2% of patients with ACD and AHA, respectively.

Conclusions: Anaemia in SLE usually takes the form of ACD and IDA, however autoimmune haemolysis is not uncommon. SLE patients with different causes of anaemia differ in regard to several immunological parameters. Epo response is blunted in anaemic SLE patients, particularly those with ACD and AHA.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relation of the log10 serum erythropoietin concentration to haemoglobin concentrations. In patients with ACD and AHA, the slope of the regression (b=0.024, p=0.53 and b=−0.002, p=0.97 respectively) was lower than in the controls (b=−0.110, p=0.003) who included 20 patients with uncomplicated iron deficiency anaemia. ACD: anaemia of chronic disease; AHA: autoimmune haemolytic anaemia; IDA: iron deficiency anaemia.
Figure 2
Figure 2
Kaplan-Meier plots for the time to correction of anaemia for different causes. Abbreviations as in figure 1.
See this image and copyright information in PMC

References

    1. Arthritis Rheum. 1982 Nov;25(11):1271-7 - PubMed
    1. Am J Med. 1978 Aug;65(2):342-5 - PubMed
    1. J Clin Invest. 1985 May;75(5):1496-503 - PubMed
    1. J Rheumatol. 1985 Aug;12(4):798-9 - PubMed
    1. Am J Med. 1986 Nov;81(5):935-8 - PubMed

MeSH terms